Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Klunk

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Diagnosis of Alzheimer's disease: two decades of progress." Diagnosis of Alzheimer's disease: walking a well-paved pathWilliam E Klunk
Neurobiology of Aging|May 16, 2002
Blood and CSF biomarkers for AD revisited: what's new, what's good, and is this where we should be looking?William E Klunk
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Molecular imaging: What is right and what is an illusion?William E Klunk
Neurobiology of Aging|November 15, 2011
Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementiaWilliam E Klunk
Archives of Neurology|October 15, 2008
Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twistWilliam E Klunk
Neurology|October 18, 2013
Amyloid and neurodegeneration: converging and diverging pathsWilliam E Klunk, Daniela Perani
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2013
Disclosure of amyloid imaging results to research participants: has the time come?Jennifer H Lingler, William E Klunk
Current Opinion in Neurology|November 8, 2008
The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferationWilliam E Klunk, Chester A Mathis
Alzheimer Disease and Associated Disorders|September 5, 2008
Whatever happened to Pittsburgh Compound-A?William E Klunk, Chester A Mathis
Neurology|September 14, 2012
Predicting positivity for a new era of Alzheimer disease prevention trialsJeffrey M Burns, William E Klunk
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Diagnosis of Alzheimer's disease: two decades of progress." Diagnosis of Alzheimer's disease: walking a well-paved pathWilliam E Klunk
Neurobiology of Aging|May 16, 2002
Blood and CSF biomarkers for AD revisited: what's new, what's good, and is this where we should be looking?William E Klunk
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Molecular imaging: What is right and what is an illusion?William E Klunk
Neurobiology of Aging|November 15, 2011
Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementiaWilliam E Klunk
Archives of Neurology|October 15, 2008
Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twistWilliam E Klunk
Neurology|October 18, 2013
Amyloid and neurodegeneration: converging and diverging pathsWilliam E Klunk, Daniela Perani
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2013
Disclosure of amyloid imaging results to research participants: has the time come?Jennifer H Lingler, William E Klunk
Current Opinion in Neurology|November 8, 2008
The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferationWilliam E Klunk, Chester A Mathis
Alzheimer Disease and Associated Disorders|September 5, 2008
Whatever happened to Pittsburgh Compound-A?William E Klunk, Chester A Mathis
Neurology|September 14, 2012
Predicting positivity for a new era of Alzheimer disease prevention trialsJeffrey M Burns, William E Klunk
Pageof 24